84. Facial Lesions
1. : A facial skin lesion is a flaw that could be a lump, crack, ulcer or abnormal discoloration of the skin that is not normally present. A lesion is described as benign when it is harmless. It is described as malignant when it is a sign of skin cancer and is potentially dangerous. The most common causes of skin lesions are injury, aging, infectious diseases, allergies, and small infections of the skin or hair follicles. Chronic diseases such as
diabetes or autoimmune disorders can cause skin lesions. Skin cancer or precancerous changes also appear as skin lesions. A skin lesion is an abnormal lump, bump, ulcer, sore or colored area on the skin. Common skin lesions include moles and actinic keratosis, among others. Medications. First-line treatments are often topical medications to help treat the
inflammation and protect the affected area. Topical medication can also provide mild symptom relief to stop pain, itching, or burning caused by the skin lesion. Malignant lesions of the skin are common. Patients who develop squamous cell carcinoma and
malignant melanoma often have recognizable precursor conditions. A few skin lesions resemble malignancies. Lesions that are growing, spreading or pigmented or those that occur on exposed areas of skin are of particular concern.
High Impact List of Articles
-
C-reactive protein and hepatocellular carcinoma: analysis of its relationships to tumor factors
Brian I. Carr*, Hikmet Akkiz, Vito Guerra, Ahmet Uygun, Ali Demir, Sezai Yilmaz, Yaman Tokat, et al
Research Article: Clinical Practice
-
C-reactive protein and hepatocellular carcinoma: analysis of its relationships to tumor factors
Brian I. Carr*, Hikmet Akkiz, Vito Guerra, Ahmet Uygun, Ali Demir, Sezai Yilmaz, Yaman Tokat, et al
Research Article: Clinical Practice
-
Favorable cardiovascular effects of pioglitazone: a meta-analysis
Katya Hristova Uzunova*, Elena Pavlova Filipova, Krassimir Boytchev Kalinov & Toni Yonkov Vekov
Review Article: Clinical Practice
-
Favorable cardiovascular effects of pioglitazone: a meta-analysis
Katya Hristova Uzunova*, Elena Pavlova Filipova, Krassimir Boytchev Kalinov & Toni Yonkov Vekov
Review Article: Clinical Practice
-
Diagnosis and treatment of myelofibrosis: a personal perspective
Sabia Rashid, Deepti H Radia, Claire N Harrison
Perspective Article: Clinical Practice
-
Diagnosis and treatment of myelofibrosis: a personal perspective
Sabia Rashid, Deepti H Radia, Claire N Harrison
Perspective Article: Clinical Practice
-
Bulletin Board: Volume 8 Issue 1
Bulletin Board: Clinical Practice
-
Bulletin Board: Volume 8 Issue 1
Bulletin Board: Clinical Practice
-
Improved patient care with better malaria diagnosis
David Schellenberg, Barbara Willey and Martin P Grobusch
Editorial: Clinical Practice
-
Improved patient care with better malaria diagnosis
David Schellenberg, Barbara Willey and Martin P Grobusch
Editorial: Clinical Practice
-
Beyond lipid-lowering therapy: does ezetimibe enhance the effects of statins on atherosclerosis?
Suresh Krishnamoorthy and Gregory YH Lip
Editorial: Clinical Practice
-
Beyond lipid-lowering therapy: does ezetimibe enhance the effects of statins on atherosclerosis?
Suresh Krishnamoorthy and Gregory YH Lip
Editorial: Clinical Practice
-
Avoiding surgery in prostate cancer patients with low-risk disease
Vladimir Mouraviev andThomas J Polascik
Perspective: Clinical Practice
-
Avoiding surgery in prostate cancer patients with low-risk disease
Vladimir Mouraviev andThomas J Polascik
Perspective: Clinical Practice
-
Appendices: Volume 4 Issue 6
Appendices: Clinical Practice
-
Appendices: Volume 4 Issue 6
Appendices: Clinical Practice
-
Management of transitional cell carcinoma by targeting the epidermal growth factor receptor
Nicholas R Brook, Alex J Colquhoun and J Kilian Mellon
Review Article: Clinical Practice
-
Management of transitional cell carcinoma by targeting the epidermal growth factor receptor
Nicholas R Brook, Alex J Colquhoun and J Kilian Mellon
Review Article: Clinical Practice
Relevant Topics in Clinical